A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer
Clinical trial NCT04188548 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04188548
- Sponsor
- Eli Lilly and Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-10
- Primary completion
- 2020-06-29
- Enrollment
- 379
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.